Bronchial Artery Embolisation for Massive Haemoptysis: Immediate and Long-Term Outcomes—A Retrospective Study
Autor: | R. Frood, Saeed Mirsadraee, Simon J. McPherson, Shishir Karthik, Ian Clifton, Karen Flood |
---|---|
Rok vydání: | 2020 |
Předmět: |
Therapeutic embolisation
Pulmonary and Respiratory Medicine medicine.medical_specialty Bronchial arteries 030218 nuclear medicine & medical imaging 03 medical and health sciences 0302 clinical medicine Pharmacotherapy Respiratory Care medicine.artery Long term outcomes Medicine Pulmonary pathology Major complication Stroke Original Research lcsh:RC705-779 business.industry High mortality Haemoptysis Retrospective cohort study lcsh:Diseases of the respiratory system medicine.disease Surgery 030228 respiratory system business Bronchial artery |
Zdroj: | Pulmonary Therapy, Vol 6, Iss 1, Pp 107-117 (2020) Pulmonary Therapy |
ISSN: | 2364-1746 2364-1754 |
DOI: | 10.1007/s41030-020-00112-x |
Popis: | Introduction Bronchial artery embolisation (BAE) is an established treatment method for massive haemoptysis. The aim of this study is to evaluate the impact of BAE on in-hospital outcomes and long-term survival in patients with massive haemoptysis. Methods Retrospective review of all cases of acute massive haemoptysis treated by BAE between April 2000 and April 2012 with at least a 5 year follow up of each patient. Targeted BAE was performed in cases with lateralising symptoms, bronchoscopic sites of bleeding or angiographic unilateral abnormal vasculature. In the absence of lateralising symptoms or signs, bilateral BAE was performed. Results 96 BAEs were performed in 68 patients. The majority (64 cases, 67%) underwent unilateral procedures. 83 (86.5%) procedures resulted in immediate/short term control of haemoptysis which lasted for longer than a month. The mean duration of haemoptysis free period after embolisation was 96 months. There were three major complications (cardio-pulmonary arrest, paraparesis and stroke). 38 (56%) patients were still alive at least 5 years following their BAE. Benign causes were associated with significantly longer haemoptysis free periods, mean survival 108 months compared to 32 months in patients with an underlying malignant cause (p = 0.005). An episode of haemoptysis within a month of the initial embolisation was associated reduced overall survival (p = 0.033). Conclusion BAE is effective in controlling massive haemoptysis. Long-term survival depends on the underlying pulmonary pathology. Strategies are required to avoid incomplete initial embolisation, which is associated with ongoing haemoptysis and high mortality despite further BAE. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |